This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
NanoVibronix Beheer
Beheer criteriumcontroles 3/4
We currently do not have sufficient information about the CEO.
Belangrijke informatie
Brian Murphy
Algemeen directeur
US$404.9k
Totale compensatie
| Percentage CEO-salaris | 57.0% |
| Dienstverband CEO | 6.6yrs |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | 6.6yrs |
| Gemiddelde ambtstermijn bestuur | 8.1yrs |
Recente managementupdates
Recent updates
Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Dec 31 2022 | n/a | n/a | -US$5m |
| Sep 30 2022 | n/a | n/a | -US$6m |
| Jun 30 2022 | n/a | n/a | -US$12m |
| Mar 31 2022 | n/a | n/a | -US$10m |
| Dec 31 2021 | US$405k | US$231k | -US$14m |
| Sep 30 2021 | n/a | n/a | -US$13m |
| Jun 30 2021 | n/a | n/a | -US$7m |
| Mar 31 2021 | n/a | n/a | -US$8m |
| Dec 31 2020 | US$365k | US$231k | -US$4m |
| Sep 30 2020 | n/a | n/a | -US$5m |
| Jun 30 2020 | n/a | n/a | -US$4m |
| Mar 31 2020 | n/a | n/a | -US$4m |
| Dec 31 2019 | US$512k | US$231k | -US$6m |
| Sep 30 2019 | n/a | n/a | -US$6m |
| Jun 30 2019 | n/a | n/a | -US$6m |
| Mar 31 2019 | n/a | n/a | -US$6m |
| Dec 31 2018 | US$591k | US$231k | -US$4m |
| Sep 30 2018 | n/a | n/a | -US$5m |
| Jun 30 2018 | n/a | n/a | -US$5m |
| Mar 31 2018 | n/a | n/a | -US$6m |
| Dec 31 2017 | US$529k | US$189k | -US$6m |
| Sep 30 2017 | n/a | n/a | -US$5m |
| Jun 30 2017 | n/a | n/a | -US$4m |
| Mar 31 2017 | n/a | n/a | -US$3m |
| Dec 31 2016 | US$103k | US$32k | -US$3m |
Compensatie versus markt: Brian's total compensation ($USD404.94K) is about average for companies of similar size in the German market ($USD418.12K).
Compensatie versus inkomsten: Brian's compensation has increased whilst the company is unprofitable.
CEO
Brian Murphy (65 yo)
6.6yrs
Tenure
US$404,939
Compensatie
Mr. Brian M. Murphy has been the Chief Executive Officer of NanoVibronix Inc. since October 13, 2016. Mr. Murphy has sales, operations and general management experience in medical devices and medical techn...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Director | 6.6yrs | US$404.94k | geen gegevens | |
| CFO & Accounting Officer | 2.6yrs | US$271.49k | 0.012% € 664.1 | |
| Chief Medical Officer & Director | 9.2yrs | US$8.29k | 0.037% € 2.1k | |
| Vice President of Marketing | no data | geen gegevens | geen gegevens | |
| Vice President of Sales | no data | geen gegevens | geen gegevens |
6.6yrs
Gemiddelde duur
66yo
Gemiddelde leeftijd
Ervaren management: 56R0's management team is seasoned and experienced (6.6 years average tenure).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Director | 6.6yrs | US$404.94k | geen gegevens | |
| Chief Medical Officer & Director | 19.7yrs | US$8.29k | 0.037% € 2.1k | |
| Member of Medical Advisory Board | no data | geen gegevens | geen gegevens | |
| Independent Director | 8.1yrs | US$48.62k | 0.15% € 8.3k | |
| Independent Chairman of the Board | 6.6yrs | US$214.82k | 0.23% € 12.5k | |
| Member of Medical Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Medical Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Medical Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Medical Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Medical Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Medical Advisory Board | no data | geen gegevens | geen gegevens | |
| Independent Director | 8.1yrs | US$46.06k | 0% € 0 |
8.1yrs
Gemiddelde duur
68.5yo
Gemiddelde leeftijd
Ervaren bestuur: 56R0's board of directors are considered experienced (8.1 years average tenure).